Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Optic Neuritis 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Myelitis, Transverse 1Multiple Sclerosis 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell 1Cerebellar Diseases 1Burkitt Lymphoma 1

Interventions

fludarabine 2Fingolimod Hydrochloride 2Cyclophosphamide 2Blood Specimen Collection 2teriflunomide 1gadobutrol 1gadobenic acid 1Surveys and Questionnaires 1Specimen Handling 1Respiratory Therapy 1Registries 1Platelet Transfusion 1Phlebotomy 1OM 89 1Nivolumab 1Natalizumab 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Interferon beta-1a 1Gadolinium DTPA 1Fish Oils 1Exergaming 1Dimethyl Fumarate 1Dietary Fiber 1Data Collection 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Multiple Sclerosis × Interferon beta-1a × Clear all
NCT00179478 2017-09-06

CHAMPIONS10

Beth Israel Deaconess Medical Center

Phase 4 Completed
155 enrolled 10 charts

Cerebellar Diseases, Multiple Sclerosis, Myelitis, Transverse, Optic Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡